Glenmark Pharma gets USFDA nod for seizure treatment drug
The approval by the US Food & Drug Administration (USFDA) is for Topiramate capsules of strengths 15 mg and 25 mg, Glenmark Pharmaceuticals said in a statement.
![Glenmark Pharma gets USFDA nod for seizure treatment drug](https://cdn.zeebiz.com/sites/default/files/2024/07/17/305245-glenmark.jpg?im=FitAndFill=(1200,900))
The company said its current portfolio consists of 198 products authorised for distribution in the US marketplace and 50 ANDAs pending approval with the USFDA.